Theodore R. Samuels II has bought stock on 12 days since Feb 2017

Theodore R. Samuels II is a retired financial executive serving as an independent director on the board of Centene Corporation since 2022, where he is a member of the Compensation and Talent Committee and Governance Committee.( He recently demonstrated confidence in the company by purchasing 9,000 shares of Centene (NYSE: CNC) common stock on July 28, 2025, at $27.62 per share for $248,580, bringing his direct ownership to 18,494.979 shares (including restricted stock units), plus 32,000 shares indirectly through a family trust where he is co-trustee, and options for 10,000 shares.(

Samuels has a distinguished career in investment management, having served as President of Capital Guardian Trust Company from 2010 to 2017 and as a global equity portfolio manager at Capital International, Inc. from 1981 to 2012.( He currently holds lead independent director positions at Bristol Myers Squibb (since 2017) and Iron Mountain Inc. (since 2023), with prior board roles at Perrigo Company (2017-2023), Auctane, Inc. (2017-2021), and others including Children's Hospital Los Angeles and Research Corporation Technologies.(

Written by Perplexity from public sources.